Comprehensive update on multiple sclerosis disease-modifying therapies. Personalized treatment algorithms are the future. - https://www.moloch.at/Lezns/2004/Haefm/Haefm.htm , Comprehensive review of monoclonal gammopathies of undetermined significance. Risk stratification tools continue to improve. .